US 10,370,363 B2Granted

Inhibitors of CXCR2

AssigneeChemoCentryx, Inc.

InventorsXi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Manmohan Reddy Leleti, Viengkham Malathong, Jeffrey McMahon, Hiroko Tanaka, Ju Yang, Chao Yu, Penglie Zhang, Venkat Mali

Life of this patent

Estimating the term…

Abstract

Compounds are provided as inhibitors of CXCR2, having the structure:

Claims13

Dependent claims

A compound having formula

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/722,785Filed 2 Oct 2017 · continuation
Priority: 19 Nov 2015
Published: US 2018/0170916 A121 Jun 2018
Granted: 6 Aug 2019
Term ends: Not estimatedThe source records don’t support an estimate.

Classification17 codes

C07D 405/12
Containing two hetero rings: linked by a chain containing hetero atoms as chain links
A61K 31/4035
Condensed with carbocyclic rings, e.g. carbazole: isoindoles, e.g. phthalimide
A61K 31/422
Oxazoles: not condensed and containing further heterocyclic rings
A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Family

Application62/257,529Us provisional application · filed 19 Nov 2015
Application15/353,949Parent of this continuation · filed 17 Nov 2016
US 2018/0170916 A1Pre-grant publication · published 21 Jun 2018
US 9,809,581 B2Parent of this continuation
US 2017/0144996 A1Published application
US 10,370,363 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results